Navigation Links
Echo Therapeutics Announces Second Quarter 2011 Financial Results
Date:8/12/2011

ith Echo's CEO, Dr. Patrick Mooney, was posted on May 31, 2011.  On June 8, 2011, Dr. Stanley Nasraway, Director of the Surgical Intensive Care Units at Tufts Medical Center and ICU glycemic control thought leader discussed Echo's Symphony tCGM System in his BioMedReports article, "Tight Glycemic Control: What do we really know, and what should we expect?"
  • Echo's common stock began trading on The NASDAQ Capital Market on June 29, 2011. Echo continues to trade under the ticker symbol "ECTE."
  • Equity research coverage of Echo was initiated by Morgan Joseph TriArtisan, JMP Securities, Feltl and Company, Chardan Capital Markets, and Noble Financial Capital Markets.

  • "Our progress during the first half of 2011 is exemplified by the continued advancement of our Symphony tCGM System, the appointment of Chris Schnittker as Chief Financial Officer, and the move to Nasdaq," commented Patrick T. Mooney, M.D., Chairman and Chief Executive Officer of Echo Therapeutics. "As we head into the second half of the year, our focus is to drive Symphony through clinical trials and, ultimately, to the market.  With several important milestones still ahead, we look forward to continued progress and increased shareholder value."

    First Quarter 2011 Financial ResultsFor the six months ended June 30, 2011, Echo reported approximately $243,000 in licensing revenue compared to $182,000 revenue in the first half of 2010. The company increased operating expenses by 5% to $3.8 million compared to $3.6 million during the first half of 2010. This increase included an 11% increase in research and development and almost no change in selling, general and administrative expenses. The net loss and ne
    '/>"/>

    SOURCE Echo Therapeutics, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Halozyme Therapeutics to Present at the Wedbush 2011 Global Healthcare Conference on August 17
    2. Prime Therapeutics Announces Pharmacy Offering with Guaranteed Net Spend Per Prescription
    3. Echo Therapeutics Unveils Symphony tCGM Demonstration Video
    4. Orexigen® Therapeutics Reports Second Quarter Ended June 30, 2011 Financial Results
    5. Echo Therapeutics Announces Multiple Patents and Trademark Grants
    6. Nektar Therapeutics Reports Second Quarter 2011 Financial Results
    7. Silence Therapeutics Receives Notice of Allowance for New U.S. Patent Covering Novel Small Interfering RNA (siRNA) Delivery Technology
    8. Prefilled Syringes: Devices, Therapeutics, Players, Markets and Prospects
    9. Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts
    10. Argos Therapeutics Files Registration Statement for Proposed Initial Public Offering
    11. Cell Therapeutics, Inc. (CTI) Reports Reduction in Operating Expenses and Net Losses for Second Quarter and First Half 2011 Compared to 2010, and Advances In Bringing Pixantrone to Market
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/15/2014)... Norway , December 15, 2014 ... innovative drugs for aggressive drug resistant cancers, today announces ... in a private placing from new and existing investors. ... financing to support the development of its pipeline of ... program for its lead drug candidate, BGB324, a first-in-class ...
    (Date:12/15/2014)... 15, 2014 Investor-Edge has initiated coverage ... ), Eli Lilly and Company (NYSE: LLY ), ... SNY ), and Novartis AG (NYSE: NVS ... at: http://investor-edge.com/register . On Friday, December 12, ... Dow Jones Industrial Average lost 1.79%, to finish the day ...
    (Date:12/15/2014)... BOSTON , December 15, 2014 ... and development company, is pleased to announce the grant ... States relating to its GPCR-focused drug discovery ... significantly strengthens the global patent estate covering Heptares, technologies ... The suite of patents recently granted by the US ...
    Breaking Medicine Technology:BerGenBio Completes NOK90 Million Fundraising 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 3Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 4Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 5Heptares Extends Global Patent Protection for GPCR-Focused Drug Discovery Platform With Grant of Core Patents in the United States 2
    ... 12, 2011 Southern Home Medical Equipment, Inc. ... healthcare professionals and equipment to medical institutions, announced ... operations for fiscal year 2010 have been restated ... Medical Staffing. In a previous announcement ...
    ... Inc., a privately held medical device company focused on ... announced the initial launch of its Durango™ Stand-Alone ALIF ... was made at the 2011 American Association of Neurological ... The Durango system is intended to treat degenerative disc ...
    Cached Medicine Technology:Southern Home Medical Equipment Reports Additional Revenues and Profits for 2010 2Lanx®, Inc. Launches Durango™ Stand-Alone ALIF System 2
    (Date:12/17/2014)... December 17, 2014 HeartMath® Inc., ... on stress, heart rate variability (HRV), heart coherence ... its extensive HRV databases and algorithms to chipset ... will enable HeartMath’s partners to offer its HRV ... research, as well as its normative HRV databases ...
    (Date:12/17/2014)... NY (PRWEB) December 17, 2014 Project ... who recently brought videos of MIT economist and Obamacare ... best-selling author James O’Keefe conducted the interview, which is ... stated that there was intentional mislabeling in the Affordable ... in the bill: A two-hundred-and-fifty billion dollar per year ...
    (Date:12/17/2014)... Greater participation in music classes may benefit children,s language ... in the nonprofit Harmony Project, which provides music education ... Over two years, children who actively participated in the ... speech and reading, compared to those with lower levels ... in music classes occurred in the same areas of ...
    (Date:12/15/2014)... researchers have just published an important new report on ... mesothelioma. Surviving Mesothelioma has just posted an article on ... read it now. , Doctors at Harvard, MIT, ... Langone Medical Center performed complete genetic analyses on 22 ... to pinpoint the genes that are most likely to ...
    (Date:12/15/2014)... OutMarket , a provider of marketing ... Cheat Sheets ,” a guide that exposes the insider ... the top ten social media networks. , Social ... engagement, and customer service. It can also increase new ... on new networks and weather constantly changing algorithms, they ...
    Breaking Medicine News(10 mins):Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 2Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 3Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2Health News:Music Classes Boost Language Skills, Study Says 2Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3
    ... The American Association of Cardiovascular and Pulmonary Rehabilitation ... Los Angeles Biomedical Research Institute (LA BioMed) principal ... annual meeting in Milwaukee. Dr. Casaburi, who ... the Rehabilitative Sciences at LA BioMed and leads ...
    ... As a patient safety best practice and endorsement of ... Board of Directors approved and released a clinical practice ... procedure called vertebroplasty as a way to treat fractures ... avenue the Academy uses to ensure that patients receive ...
    ... By Steven Reinberg HealthDay Reporter , ... popular misconception that because sports drinks and other noncarbonated ... healthy, University of Texas researchers report. In a ... students throughout Texas, researchers found that kids who drank ...
    ... ago, the discovery of microRNAs ― tiny cellular molecules ... of scientific possibilities, including a deeper understanding of human ... gives scientists the ability to discover invaluable information about ... University researchers have developed the cutting-edge technology to better ...
    ... in daycare puts children with a chronic lung condition ... infections, according to a study from Johns Hopkins Children,s ... . The researchers say their findings should ... of age, for signs of lung disease and to ...
    ... SEPTEMBER 24, 2010 Lillian Feldshuh, of Scarsdale, NY, ... 2006, received the Courageous Patient Award yesterday at the ... DC. The procedure was a success and Feldshuh, who ... in good health. In 2006, Lillian Feldshuh suffered ...
    Cached Medicine News:Health News:LA BioMed researcher to receive prestigious honor 2Health News:New guideline finds no evidence for a popular back procedure 2Health News:New guideline finds no evidence for a popular back procedure 3Health News:Study Finds Teens Think Sports Drinks Are Healthy 2Health News:Study Finds Teens Think Sports Drinks Are Healthy 3Health News:Diving deeper into the gene pool 2Health News:Daycare puts children with lung disease at risk for serious illness 2
    Used to occupy an empty hole which is not being used in an implantablepacemaker header....
    Implantable medical grade silicone sleeve for adapting a 5 mm (01) connector to a 6 mm (02) connector....
    Implantable medical grade silicone end cap for insulation and sealing protection of 5 mm or 3.2 mm connectors....
    ... Tupos LA, the only ICD system in ... the first implant for the treatment of ... a lasting improvement of their hemodynamics and ... LA uses biatrial stimulation to effectively suppress ...
    Medicine Products: